Pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with docetaxel-pretreated, metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort E.
Work
Year: 2024
Type: article
Source: Journal of Clinical Oncology
Authors Marinela Augustin, Brigitte Laguerre, Capucine Baldini, Ahmed Zedan, Enrique González‐Billalabeitia +15 more
Institutions Paracelsus Medizinische Privatuniversität, Centre Eugène Marquis, Institut Gustave Roussy, Vejle Sygehus, Hospital Universitario 12 De Octubre +16 more
Cites:
Cited by: 1
Related to: 10
FWCI: 1.323
Citation percentile (by year/subfield): 79.53
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed